Screener / SEC EDGAR /CIK 0001758009 /10-K filed Mar 2, 2026, compared with Mar 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Software

Quantum Computing Inc. QUBT

Compare with peers Embed
Earnings releases

Latest results release: Nov 9, 2026

8-K item 2.02, exhibit 99

What QUBT's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 9, 2026 · EX-99.1

Quantum Computing Inc. Reports Third Quarter 2026 Financial Results

Open on SEC

Quantum Computing Inc. Reports Third Quarter 2026 Financial Results Third-quarter revenue of $9.5 million exceeds revenue generated during the entire first half of 2026

Acquired photonics and advanced packaging businesses contributed to commercial revenue growth while supporting QCi's quantum technology roadmap

Ends quarter with approximately $1.3 billion in cash, cash equivalents and investments

— Quantum Computing Inc. (“QCi” or the “Company”) (Nasdaq: QUBT), a vertically integrated quantum company pioneering photonics and semiconductor manufacturing, today announced financial results for the third quarter ended September 30, 2026.

QCi generated $9.5 million in revenue during the third quarter, exceeding the $9.2 million reported for the entire first half of 2026. Revenue growth was primarily driven by the Luminar Semiconductors, Inc. (“LSI”), NuCrypt, LLC (“NuCrypt”) and NHanced Semiconductors, Inc. (“NHanced”) businesses acquired during the first half of 2026, including acquired photonic components, quantum communications products and advanced packaging services sold to the aerospace, government and industrial markets. The Company continues to focus on expanding commercial relationships, integrating its manufacturing capabilities and advancing its proprietary quantum technologies as it moves into the next phase of its development.

"For several years, we've been building the technology and capabilities to make quantum more practical and accessible," said Dr. Yuping Huang, Chief Executive Officer of QCi. "We're starting to see those investments come together, and our focus is increasingly shifting from what we can build to what we can put to work for customers. We're encouraged by our progress, but recognize there's considerable work ahead. Our priorities are clear: growing our commercial business, scaling manufacturing and advancing our quantum roadmap. I've always believed that being early creates opportunity. Execution is what makes that opportunity last."

• Revenue : Third-quarter revenue totaled $9.5 million, compared to $384 thousand in the third quarter of 2025. Revenue was primarily driven by sales of products and services for aerospace, government and industrial applications.

• Gross Margin : Gross profit totaled approximately $428 thousand in the third quarter, for a gross margin of 4.5%. The Company continues to focus on increasing manufacturing utilization and improving operating efficiency as it scales its commercial operations.

• Operating expenses : Total operating expenses were $29.0 million, compared with $10.5 million in the prior-year period. The increase is primarily due to higher personnel expenses and other costs associated with expanded research and development, sales and marketing activities, as well as approximately $1.0 million in acquisition-related expenses. 1 • Interest and other income : Interest and other income totaled $13.0 million, compared with $3.5 million in the third quarter of 2025, primarily reflecting interest earned on the Company's larger cash and investment balances.

• Net loss : The Company reported a net loss of $15.1 million, or $0.07 per basic share, for the third quarter of 2026.

• Balance sheet : QCi ended the quarter with approximately $1.3 billion in cash, cash equivalents and investments and accrued interest, including $174.3 million in cash and cash equivalents and $1.1 billion in short- and long-term investments, including accrued interest consistent with its reported position at the end of the third quarter.

• Contract backlog : Contract backlog totaled approximately $39.1 million as of September 30, 2026. Contract backlog represents the value of contracted work expected to be performed under applicable contracts and remains subject to the terms and conditions of those contracts.

• Expanding commercial opportunities : QCi continued integrating the LSI, NuCrypt and NHanced businesses acquired during the first half of 2026. These businesses provide established quantum, photonics and advanced packaging products, services and customer relationships across existing commercial markets, while expanding QCi's capabilities in photonic design, semiconductor fabrication and advanced packaging. Together, these capabilities support two important objectives: serving customers in established markets today and advancing the development and manufacturing of QCi's proprietary quantum technologies. The Company is focused on expanding customer relationships, bringing its manufacturing operations together and improving efficiency as it scales the business. • Advancing quantum adoption through academic collaboration : In September, QCi entered into a framework agreement with Hamad Bin Khalifa University in Qatar to support quantum education, research, and co-marketing initiatives to accelerate the adoption of quantum technologies. The collaboration includes cloud access to QCi's Dirac-3 quantum optimization system and is intended to support research and expand understanding of potential applications for quantum computing, sensing and communications. • Delivering QCi’s quantum technology to pharmaceutical markets: During the quarter, QCi entered into a commercial agreement with INmune Bio to apply QCi’s Dirac quantum optimization technology alongside AI and conventional analytics to clinical and biomedical data. The collaboration will explore potential applications for INmune Bio's investigational Alzheimer's treatment. 2 The engagement marks QCi's first commercial customer in the pharmaceutical and biotechnology market, and an opportunity to apply QCi’s quantum technology to complex, real-world challenges.

QCi will host a conference call to discuss its third-quarter 2026 results on Monday, November 9, 2026, at 4:30 p.m. Eastern Time.

To access the live webcast of the conference call, visit the QCi Investor Relations page at https://quantumcomputinginc.com/investor-relations. Investors may also access the webcast via the following link: https://www.webcaster5.com/Webcast/Page/3051/54638.

To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled start time. International callers please dial (973) 528-0011. Callers should use access code: 822805.

A replay of the teleconference will be available until November 23, 2026, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use conference ID: 54638.

Quantum Computing Inc. (Nasdaq: QUBT) is an integrated quantum photonics company developing and manufacturing technologies that use light to compute complex information, capture hard-to-detect signals and communicate more securely. QCi brings together quantum optics, integrated photonics, semiconductor manufacturing and advanced packaging to create a more direct path from advanced science to practical products.

QCi's portfolio includes quantum machines, photonic chips, components, modules and subsystems, as well as foundry and advanced manufacturing services. Its technologies are designed to operate at room temperature and low power, without the specialized cooling infrastructure required by many quantum approaches. These advantages enable deployment across computing and AI, secure communications, sensing and imaging, aerospace and defense, and other demanding applications.

Headquartered in Hoboken, New Jersey, QCi has operations across the United States. By combining deep physics, device engineering and scalable manufacturing, QCi is working to make quantum and advanced photonic technologies more accessible and useful in the real world.

To learn more about QCi and its approach to harnessing light for practical quantum computing, please visit www.quantumcomputinginc.com .

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expectations of future results, operating performance, revenue growth, gross margin, backlog, customer relationships, revenue recognition and funding under the post-quarter subcontract, the negotiation of any definitive contract, manufacturing utilization and efficiency, operational expansion, business strategy, integration of recent acquisitions, commercialization and adoption of quantum and photonic products, and the potential application of QCi’s technology in academic, pharmaceutical, biotechnology, government, aerospace, industrial and other markets are forward- looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to, future demand for quantum and photonic products, the Company’s ability to scale its technology and manufacturing capabilities, the Company’s ability to integrate and benefit from recent acquisitions, not limited to future demand for quantum and photonic products, our ability to convert backlog, contracts and commercial opportunities into revenue, customer termination or non-funding of contracts or subcontracts, the inability to negotiate a definitive contract or realize the full ceiling amount of any subcontract, the Company’s ability to scale its technology and manufacturing capabilities, the Company’s ability to integrate and benefit from recent acquisitions, the Company’s ability to achieve expected manufacturing utilization, operating efficiency and margin improvements, the Company’s ability to commercialize and drive adoption of its products and technologies and the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at https://quantumcomputinginc.com/investor-relations, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward- looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. 4

September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────────────── Assets Current assets: Cash and cash equivalents $ 174,280 $ 737,880 Accounts receivable, net 8,316 519 Inventory 10,634 352 Short-term investments 727,334 379,421 Accrued interest receivable 6,752 3,634 Prepaid expenses and other current 7,046 11,914 assets Total current assets 934,362 1,133,720 Property and equipment, net 43,063 12,971 Operating lease 26,919 2,353 right-of-use assets Intangible assets, net 62,094 6,500 Goodwill 160,330 55,573 Long-term investments 396,200 403,121 Accrued interest receivable 3,469 4,551 - long term Other non-current assets 1,082 131 Total assets $ 1,627,519 $ 1,618,920 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 3,679 $ 778 Accrued expenses 6,709 9,135 Deferred revenue 4,162 395 Other current liabilities 2,959 766 Total current liabilities 17,509 11,074 Derivative liability 528 7,773 Operating lease liabilities 24,716 1,808 Contingent liabilities 3,769 — Other non-current 1,184 — liabilities Total liabilities 47,706 20,655 Commitments and Contingencies Stockholders’ equity: Preferred stock, $0.0001 par value, 1,550 shares Series A Preferred Stock authorized; no shares issued and outstanding as of September 30, 2026 and December 31, 2025, - - respectively; 3,080 shares of Series B Preferred Stock authorized; no shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively Common stock, $0.0001 par value, 450,000 shares authorized; 226,932 and 224,165 shares issued and 23 22 outstanding as of September 30, 2026 and December 31, 2025, respectively Additional paid-in capital 1,838,563 1,816,494 Accumulated deficit -250,104 -219,156 Accumulated other comprehensive income -8,669 905 (loss) Total stockholders’ equity 1,579,813 1,598,265 Total liabilities and stockholders’ $ 1,627,519 $ 1,618,920 equity

Full text with the tables
      Quantum Computing Inc. Reports Third Quarter 2026 Financial Results       
Third-quarter revenue of $9.5 million exceeds revenue generated during the
entire first half of 2026

Acquired photonics and advanced packaging businesses contributed to commercial
revenue growth while supporting QCi's quantum technology roadmap

Ends quarter with approximately $1.3 billion in cash, cash equivalents and
investments
                                                                                
  HOBOKEN, N.J., November 9, 2026                                               
                                                                                
— Quantum Computing Inc. (“QCi” or the “Company”) (Nasdaq: QUBT), a vertically
integrated quantum company pioneering photonics and semiconductor manufacturing,
today announced financial results for the third quarter ended September 30,
2026.

QCi generated $9.5 million in revenue during the third quarter, exceeding the
$9.2 million reported for the entire first half of 2026. Revenue growth was
primarily driven by the Luminar Semiconductors, Inc. (“LSI”), NuCrypt, LLC
(“NuCrypt”) and NHanced Semiconductors, Inc. (“NHanced”) businesses acquired
during the first half of 2026, including acquired photonic components, quantum
communications products and advanced packaging services sold to the aerospace,
government and industrial markets. The Company continues to focus on expanding
commercial relationships, integrating its manufacturing capabilities and
advancing its proprietary quantum technologies as it moves into the next phase
of its development.

"For several years, we've been building the technology and capabilities to make
quantum more practical and accessible," said Dr. Yuping Huang, Chief Executive
Officer of QCi. "We're starting to see those investments come together, and our
focus is increasingly shifting from what we can build to what we can put to work
for customers. We're encouraged by our progress, but recognize there's
considerable work ahead. Our priorities are clear: growing our commercial
business, scaling manufacturing and advancing our quantum roadmap. I've always
believed that being early creates opportunity. Execution is what makes that
opportunity last."
                                                                                
  Third Quarter 2026 Financial Highlights                                       
                                                                                
• Revenue : Third-quarter revenue totaled $9.5 million, compared to $384
thousand in the third quarter of 2025. Revenue was primarily driven by sales of
products and services for aerospace, government and industrial applications.

• Gross Margin : Gross profit totaled approximately $428 thousand in the third
quarter, for a gross margin of 4.5%. The Company continues to focus on
increasing manufacturing utilization and improving operating efficiency as it
scales its commercial operations.

• Operating expenses : Total operating expenses were $29.0 million, compared
with $10.5 million in the prior-year period. The increase is primarily due to
higher personnel expenses and other costs associated with expanded research and
development, sales and marketing activities, as well as approximately $1.0
million in acquisition-related expenses.
                                                                               1
• Interest and other income : Interest and other income totaled $13.0 million,
compared with $3.5 million in the third quarter of 2025, primarily reflecting
interest earned on the Company's larger cash and investment balances.

• Net loss : The Company reported a net loss of $15.1 million, or $0.07 per
basic share, for the third quarter of 2026.

• Balance sheet : QCi ended the quarter with approximately $1.3 billion in cash,
cash equivalents and investments and accrued interest, including $174.3 million
in cash and cash equivalents and $1.1 billion in short- and long-term
investments, including accrued interest consistent with its reported position at
the end of the third quarter.

• Contract backlog : Contract backlog totaled approximately $39.1 million as of
September 30, 2026. Contract backlog represents the value of contracted work
expected to be performed under applicable contracts and remains subject to the
terms and conditions of those contracts.
                                                                                
  Third Quarter 2026 Business Highlights                                        
                                                                                
• Expanding commercial opportunities : QCi continued integrating the LSI,
NuCrypt and NHanced businesses acquired during the first half of 2026. These
businesses provide established quantum, photonics and advanced packaging
products, services and customer relationships across existing commercial
markets, while expanding QCi's capabilities in photonic design, semiconductor
fabrication and advanced packaging.
Together, these capabilities support two important objectives: serving customers
in established markets today and advancing the development and manufacturing of
QCi's proprietary quantum technologies. The Company is focused on expanding
customer relationships, bringing its manufacturing operations together and
improving efficiency as it scales the business.
• Advancing quantum adoption through academic collaboration : In September, QCi
entered into a framework agreement with Hamad Bin Khalifa University in Qatar to
support quantum education, research, and co-marketing initiatives to accelerate
the adoption of quantum technologies.
The collaboration includes cloud access to QCi's Dirac-3 quantum optimization
system and is intended to support research and expand understanding of potential
applications for quantum computing, sensing and communications.
• Delivering QCi’s quantum technology to pharmaceutical markets: During the
quarter, QCi entered into a commercial agreement with INmune Bio to apply QCi’s
Dirac quantum optimization technology alongside AI and conventional analytics to
clinical and biomedical data. The collaboration will explore potential
applications for INmune Bio's investigational Alzheimer's treatment.
                                                                               2
The engagement marks QCi's first commercial customer in the pharmaceutical and
biotechnology market, and an opportunity to apply QCi’s quantum technology to
complex, real-world challenges.
                                                                                
  Earnings Conference Call                                                      
                                                                                
QCi will host a conference call to discuss its third-quarter 2026 results on
Monday, November 9, 2026, at 4:30 p.m. Eastern Time.

To access the live webcast of the conference call, visit the QCi Investor
Relations page at https://quantumcomputinginc.com/investor-relations. Investors
may also access the webcast via the following link:
https://www.webcaster5.com/Webcast/Page/3051/54638.

To participate in the call by phone, dial (888) 506-0062 approximately five
minutes prior to the scheduled start time. International callers please dial
(973) 528-0011. Callers should use access code: 822805.

A replay of the teleconference will be available until November 23, 2026, and
may be accessed by dialing (877) 481-4010. International callers may dial (919)
882-2331. Callers should use conference ID: 54638.
                                                                                
  About Quantum Computing Inc.                                                  
                                                                                
Quantum Computing Inc. (Nasdaq: QUBT) is an integrated quantum photonics company
developing and manufacturing technologies that use light to compute complex
information, capture hard-to-detect signals and communicate more securely. QCi
brings together quantum optics, integrated photonics, semiconductor
manufacturing and advanced packaging to create a more direct path from advanced
science to practical products.

QCi's portfolio includes quantum machines, photonic chips, components, modules
and subsystems, as well as foundry and advanced manufacturing services. Its
technologies are designed to operate at room temperature and low power, without
the specialized cooling infrastructure required by many quantum approaches.
These advantages enable deployment across computing and AI, secure
communications, sensing and imaging, aerospace and defense, and other demanding
applications.

Headquartered in Hoboken, New Jersey, QCi has operations across the United
States. By combining deep physics, device engineering and scalable
manufacturing, QCi is working to make quantum and advanced photonic technologies
more accessible and useful in the real world.

To learn more about QCi and its approach to harnessing light for practical
quantum computing, please visit www.quantumcomputinginc.com .
                                                                                
  Company Contacts                                                              
                                                                                
Investor Relations:

David Moskowitz, Head of Investor Relations

[email protected]
                                                                               3
Media & Communications:

Karen Jeffers, Director, Marketing and Communications

[email protected]

Agency Contact:

IMS Investor Relations

John Nesbett/Zach Nevas

[email protected]
                                                                                
  Forward-Looking Statements                                                    
                                                                                
This press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. We intend such forward-looking
statements to be covered by the safe harbor provisions for forward looking
statements contained in Section 27A of the Securities Act of 1933, as amended
(the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”). All statements contained in this press release
other than statements of historical fact, including, without limitation,
statements regarding our expectations of future results, operating performance,
revenue growth, gross margin, backlog, customer relationships, revenue
recognition and funding under the post-quarter subcontract, the negotiation of
any definitive contract, manufacturing utilization and efficiency, operational
expansion, business strategy, integration of recent acquisitions,
commercialization and adoption of quantum and photonic products, and the
potential application of QCi’s technology in academic, pharmaceutical,
biotechnology, government, aerospace, industrial and other markets are forward-
looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,”
“continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,”
“would,” “project,” “plan,” “target,” and similar expressions are intended to
identify forward-looking statements, though not all forward-looking statements
use these words or expressions. These statements are neither promises nor
guarantees, but involve known and unknown risks, uncertainties and other
important factors that may cause our actual results, performance or achievements
to be materially different from any future results, performance or achievements
expressed or implied by the forward-looking statements, including but not
limited to, future demand for quantum and photonic products, the Company’s
ability to scale its technology and manufacturing capabilities, the Company’s
ability to integrate and benefit from recent acquisitions, not limited to future
demand for quantum and photonic products, our ability to convert backlog,
contracts and commercial opportunities into revenue, customer termination or
non-funding of contracts or subcontracts, the inability to negotiate a
definitive contract or realize the full ceiling amount of any subcontract, the
Company’s ability to scale its technology and manufacturing capabilities, the
Company’s ability to integrate and benefit from recent acquisitions, the
Company’s ability to achieve expected manufacturing utilization, operating
efficiency and margin improvements, the Company’s ability to commercialize and
drive adoption of its products and technologies and the factors, risks and
uncertainties included in our Annual Report on Form 10-K for the fiscal year
ended December 31, 2025, as such factors may be updated from time to time in our
other filings with the Securities and Exchange Commission (the “SEC”),
accessible on the SEC’s website at www.sec.gov and the Investor Relations
section of our website at https://quantumcomputinginc.com/investor-relations,
which could cause our actual results to differ materially from those indicated
by the forward-looking statements made in this press release. Any such forward-
looking statements represent management’s estimates as of the date of this press
release. While we may elect to update such forward-looking statements at some
point in the future, we disclaim any obligation to do so, even if subsequent
events cause our views to change.
                                                                               4
                                                                                
                             QUANTUM COMPUTING INC.                             
                                                                                
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) 
                                                                                
                (Unaudited, in thousands, except per share data)                
                                                                                
              Th…                                  Ni…                          
              Mo…                                  Mo…                          
              En…                                  En…                          
              Se…                                  Se…                          
        2026  30,          20…               2026  30,          20…             
 ────────────────────────────────────────────────────────────────────────────── 
  R…    $     9,…          $     384         $     18…          $     484       
  C…                                                                            
  of          9,…                258               20…                319       
  r…                                                                            
  G…                                                                            
  p…          428                126               -1…                165       
  (…                                                                            
  O…                                                                            
  e…                                                                            
  R…                                                                            
  a…          8,…               4,5…               23…               13,…       
  d…                                                                            
  S…                                                                            
  a…          5,…                787               8,…               2,1…       
  m…                                                                            
  G…                                                                            
  a…          15…               5,2…               38…               13,…       
  a…                                                                            
  T…                                                                            
  o…          29…               10,…               70…               29,…       
  e…                                                                            
  L…                                                                            
  f…          -2…               -10…               -7…               -28…       
  o…                                                                            
  N…                                                                            
  i…                                                                            
  (…                                                                            
  I…                                                                            
  a…          13…               3,5…               39…               7,0…       
  o…                                                                            
  i…                                                                            
  I…          -65                 -4               -2…               -120       
  e…                                                                            
  C…                                                                            
  in                                                                            
  f…                                                                            
  v…          458               9,2…               1,…               4,7…       
  of                                                                            
  d…                                                                            
  l…                                                                            
  I…                                                                            
  (…                                                                            
  b…          -1…               2,3…               -3…               -17…       
  i…                                                                            
  t…                                                                            
  p…                                                                            
  I…                                                                            
  t…            -                  -                 -                  -       
  p…                                                                            
  N…                                                                            
  i…                                                                            
  (…                                                                            
  a…          -1…               2,3…               -3…               -17…       
  to                                                                            
  c…                                                                            
  s…                                                                            
  O…                                                                            
  c…          -4…                -26               -9…                -26       
  l…                                                                            
  T…                                                                            
  c…    $     -1…          $    2,3…         $     -4…          $    -17…       
  i…                                                                            
  (…                                                                            
  I…                                                                            
  (…                                                                            
  p…                                                                            
  s…                                                                            
  B…                                                                            
  a…    $     -0…          $    0.01         $     -0…          $    -0.…       
  D…                                                                            
  W…                                                                            
  a…                                                                            
  s…                                                                            
  u…                                                                            
  in                                                                            
  c…                                                                            
  n…                                                                            
  i…                                                                            
  (…                                                                            
  p…                                                                            
  c…                                                                            
  s…                                                                            
  B…               225…               16…               224…               14…  
  D…               225…               16…               224…               14…  
                                                                                
                                                                               5
                                                                                
                             QUANTUM COMPUTING INC.                             
                                                                                
                     Condensed Consolidated Balance Sheets                      
                                                                                
                (Unaudited, in thousands, except par value data)                
                                                                                
                                    September 30, 2026       December 31, 2025  
 ────────────────────────────────────────────────────────────────────────────── 
  Assets                                                                        
  Current assets:                                                               
  Cash and cash equivalents      $             174,280    $            737,880  
  Accounts receivable, net                       8,316                     519  
  Inventory                                     10,634                     352  
  Short-term investments                       727,334                 379,421  
  Accrued interest receivable                    6,752                   3,634  
  Prepaid expenses and other                                                    
  current                                        7,046                  11,914  
  assets                                                                        
  Total current assets                         934,362               1,133,720  
  Property and equipment, net                   43,063                  12,971  
  Operating lease                               26,919                   2,353  
  right-of-use assets                                                           
  Intangible assets, net                        62,094                   6,500  
  Goodwill                                     160,330                  55,573  
  Long-term investments                        396,200                 403,121  
  Accrued interest receivable                    3,469                   4,551  
  - long term                                                                   
  Other non-current assets                       1,082                     131  
  Total assets                   $           1,627,519    $          1,618,920  
  Liabilities and                                                               
  Stockholders’ Equity                                                          
  Current liabilities:                                                          
  Accounts payable               $               3,679    $                778  
  Accrued expenses                               6,709                   9,135  
  Deferred revenue                               4,162                     395  
  Other current liabilities                      2,959                     766  
  Total current liabilities                     17,509                  11,074  
  Derivative liability                             528                   7,773  
  Operating lease liabilities                   24,716                   1,808  
  Contingent liabilities                         3,769                       —  
  Other non-current                              1,184                       —  
  liabilities                                                                   
  Total liabilities                             47,706                  20,655  
  Commitments and                                                               
  Contingencies                                                                 
  Stockholders’ equity:                                                         
  Preferred stock, $0.0001                                                      
  par value,                                                                    
  1,550 shares Series A                                                         
  Preferred Stock                                                               
  authorized; no shares                                                         
  issued and                                                                    
  outstanding as of September                                                   
  30, 2026 and                                                                  
  December 31, 2025,                                 -                       -  
  respectively; 3,080                                                           
  shares of Series B                                                            
  Preferred Stock                                                               
  authorized; no shares                                                         
  issued and                                                                    
  outstanding as of September                                                   
  30, 2026 and                                                                  
  December 31, 2025,                                                            
  respectively                                                                  
  Common stock, $0.0001 par                                                     
  value, 450,000                                                                
  shares authorized; 226,932                                                    
  and 224,165                                                                   
  shares issued and                                 23                      22  
  outstanding as of                                                             
  September 30, 2026 and                                                        
  December 31,                                                                  
  2025, respectively                                                            
  Additional paid-in capital                 1,838,563               1,816,494  
  Accumulated deficit                         -250,104                -219,156  
  Accumulated other                                                             
  comprehensive income                          -8,669                     905  
  (loss)                                                                        
  Total stockholders’ equity                 1,579,813               1,598,265  
  Total liabilities and                                                         
  stockholders’                  $           1,627,519    $          1,618,920  
  equity                                                                        
                                                                                
                                                                               6

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/QUBT/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.